Treace Medical Concepts (TMCI) Revenue & Revenue Breakdown
Treace Medical Concepts Revenue Highlights
Latest Revenue (Y)
$212.69M
Latest Revenue (Q)
$47.20M
Treace Medical Concepts Revenue by Period
Treace Medical Concepts Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $212.69M | 1.59% |
| 2024-12-31 | $209.36M | 11.89% |
| 2023-12-31 | $187.12M | 31.92% |
| 2022-12-31 | $141.84M | 50.22% |
| 2021-12-31 | $94.42M | 64.59% |
| 2020-12-31 | $57.37M | 45.54% |
| 2019-12-31 | $39.42M | - |
Treace Medical Concepts generated $212.69M in revenue during NA 2025, up 1.59% compared to the previous quarter, and up 370.77% compared to the same period a year ago.
Treace Medical Concepts Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-03-31 | $47.20M | -24.51% |
| 2025-12-31 | $62.52M | 24.51% |
| 2025-09-30 | $50.21M | 5.97% |
| 2025-06-30 | $47.39M | -9.86% |
| 2025-03-31 | $52.57M | -23.49% |
| 2024-12-31 | $68.71M | 52.39% |
| 2024-09-30 | $45.09M | 1.42% |
| 2024-06-30 | $44.45M | -13.02% |
| 2024-03-31 | $51.11M | -17.85% |
| 2023-12-31 | $62.21M | 52.64% |
| 2023-09-30 | $40.76M | -2.85% |
| 2023-06-30 | $41.95M | -0.57% |
| 2023-03-31 | $42.20M | -15.22% |
| 2022-12-31 | $49.77M | 50.56% |
| 2022-09-30 | $33.05M | 10.30% |
| 2022-06-30 | $29.97M | 3.17% |
| 2022-03-31 | $29.05M | -13.13% |
| 2021-12-31 | $33.44M | 54.67% |
| 2021-09-30 | $21.62M | 4.67% |
| 2021-06-30 | $20.65M | 10.41% |
| 2021-03-31 | $18.71M | -22.39% |
| 2020-12-31 | $24.11M | 68.97% |
| 2020-09-30 | $14.27M | 84.34% |
| 2020-06-30 | $7.74M | -31.25% |
| 2020-03-31 | $11.26M | - |
Treace Medical Concepts generated $47.20M in revenue during Q1 2026, up -24.51% compared to the previous quarter, and up 68.69% compared to the same period a year ago.
Treace Medical Concepts Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| EHAB | Enhabit | $1.06B | $264.80M |
| BVS | Bioventus | $568.09M | $138.65M |
| TOI | Oncology Institute | $502.73M | $147.44M |
| EOLS | Evolus | $294.96M | $72.75M |
| KIDS | OrthoPediatrics | $236.35M | $59.36M |
| TMCI | Treace Medical Concepts | $212.69M | $47.20M |
| RXST | RxSight | $134.48M | $33.64M |
| SRDX | Surmodics | $126.08M | $28.09M |
| CBLL | CeriBell | $89.06M | $26.49M |
| LAB | Standard BioTools | $85.33M | $19.55M |
| SMLR | Semler Scientific | $56.29M | $7.49M |